Interpace Biosciences, Inc. Stock
Stocks
IDXG
US46062X3035
Healthcare Facilities & Services
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.460 USD | +0.69% |
|
-4.26% | +18.68% |
| Market Cap | 40.44M 35.55M 33.1M 30.39M 57.07M 3.88B 57.83M 393M 154M 1.92B 152M 149M 6.62B | P/E 2024 |
6.84x | P/E 2025 | 1.39x |
|---|---|---|---|---|---|
| Enterprise Value | 39.12M 34.39M 32.01M 29.4M 55.21M 3.75B 55.94M 381M 149M 1.85B 147M 144M 6.4B | EV / Sales 2024 |
0.35x | EV / Sales 2025 | 0.11x |
| Free-Float |
14.74% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.69% | ||
| 1 week | -4.26% | ||
| Current month | -10.43% | ||
| 1 month | -11.52% | ||
| 3 months | -26.08% | ||
| 6 months | -16.54% | ||
| Current year | +18.68% |
| 1 week | 1.34 |  | 1.51 |
| 1 month | 1.34 | | 1.8 |
| Current year | 1.03 | | 2.4 |
| 1 year | 0.77 | | 2.4 |
| 3 years | 0.44 | | 3.54 |
| 5 years | 0.44 | | 10.33 |
| 10 years | 0.44 | | 198 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 64 | 2020-11-30 |
| Director of Finance/CFO | 34 | 2023-04-20 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Sullivan
CHM | Chairman | 79 | 2016-06-20 |
Joseph Keegan
BRD | Director/Board Member | 73 | 2015-12-31 |
Fortunato Rocca
BRD | Director/Board Member | 64 | 2020-01-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/20/26 | 1315 Capital LLC
| Conversion | Company | 9,405,941 | 212.3938% | |
| 1/20/26 | Ampersand Management LLC
| Conversion | Company | 13,861,386 | 313.0013% | |
| 2/1/24 | Free | Chief Financial Officer | 10,000 | 0.2314% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.69% | -4.26% | +62.20% | -25.13% | 40.44M | |
| -0.68% | -1.19% | +88.04% | +472.58% | 37.52B | |
| +0.74% | +5.78% | +13.70% | +37.82% | 24.34B | |
| +0.85% | -2.19% | -23.76% | -39.14% | 7.33B | |
| +0.93% | +2.52% | +7.57% | +89.66% | 4.84B | |
| +3.87% | +8.28% | +18.76% | +51.22% | 3.05B | |
| -3.31% | -6.04% | +107.12% | -18.71% | 1.81B | |
| +1.81% | +0.27% | -12.74% | -62.95% | 1.78B | |
| +2.98% | +0.04% | -28.54% | +739.21% | 1.75B | |
| +7.40% | 0.00% | +14.84% | +4.68% | 1.74B | |
| Average | +1.54% | -1.76% | +24.72% | +124.92% | 8.42B | |
| Weighted average by Cap. | +0.36% | -0.66% | +44.01% | +238.86% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 46.93M 41.25M 38.4M 35.27M 66.22M 4.5B 67.09M 456M 178M 2.22B 176M 172M 7.68B | 38.73M 34.05M 31.69M 29.11M 54.65M 3.71B 55.37M 377M 147M 1.83B 145M 142M 6.34B |
| Net income | 6.7M 5.89M 5.48M 5.04M 9.46M 643M 9.58M 65.19M 25.46M 317M 25.16M 24.62M 1.1B | 24.58M 21.6M 20.11M 18.47M 34.68M 2.36B 35.14M 239M 93.36M 1.16B 92.25M 90.26M 4.02B |
| Net Debt | 4.4M 3.86M 3.6M 3.3M 6.2M 421M 6.28M 42.75M 16.7M 208M 16.5M 16.14M 719M | -1.32M -1.16M -1.08M -994K -1.87M -127M -1.89M -12.86M -5.02M -62.6M -4.96M -4.86M -216M |
Employees
102
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | $1.460 | +0.69% | 4,002 |
| 26-07-23 | $1.450 | -3.97% | 2,536 |
| 26-07-22 | $1.510 | +0.37% | 4,632 |
| 26-07-21 | $1.504 | +0.97% | 1,217 |
| 26-07-20 | $1.490 | -2.30% | 4,423 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IDXG Stock
Select your edition
All financial news and data tailored to specific country editions
